AbbVie completes acquisition of Nimble Therapeutics to expand its immunology pipeline
Acquiring Company
AbbVie Inc.
Acquired Company
Nimble Therapeutics
North ChicagoMadisonManufacturingBiotechnologyHealthcareHealth CareTherapeuticsNon ProfitPharmaceuticalBiopharmaBiotechnologyTherapeuticsDescription
AbbVie has completed its acquisition of Nimble Therapeutics, adding novel oral peptide assets to its immunology pipeline. With this acquisition, AbbVie looks forward to integrating Nimble's proprietary technology into its R&D capabilities and welcomes the talented team at Nimble.
Quick answer
AbbVie Inc. is acquiring Nimble Therapeutics, announced January 23, 2025. AbbVie Inc. is based in North Chicago, Illinois, United States.
- How much did AbbVie Inc. pay for Nimble Therapeutics?
- The deal value was not disclosed.
- What does AbbVie Inc. do?
- Venture capital subsidiary of Abbvie
- Where are AbbVie Inc. and Nimble Therapeutics based?
- AbbVie Inc. is based in North Chicago, Illinois, United States. Nimble Therapeutics is based in Madison, Wisconsin, United States.
- Who are the decision-makers at AbbVie Inc?
- Fundz holds 2 contacts at AbbVie Inc. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Other recent acquisitions in Healthcare and Therapeutics
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Eton Pharmaceuticals completes acquisition of Galzin® (zinc acetate) from Teva Pharmaceuticals USA, Inc. to advance treatment for Wilson Disease (January 5, 2025)
- AbbVie completes acquisition of Aliada Therapeutics to enhance neuroscience development (December 11, 2024)
- GSK completes acquisition of IDRx, Inc. to enhance precision therapeutics for treating gastrointestinal stromal tumours (February 24, 2025)
- BioNTech completes acquisition of Biotheus to strengthen oncology strategy (February 4, 2025)
- Exicure, Inc. completes acquisition of GPCR Therapeutics USA Inc. to enhance its pipeline for cell and gene therapies (January 22, 2025)
- Cycle Pharmaceuticals completes acquisition of Banner Life Sciences, LLC to expand MS product portfolio (January 13, 2025)
Who to call at AbbVie Inc., and when
When AbbVie Inc. changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day AbbVie Inc. raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at AbbVie Inc., from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at AbbVie Inc.. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment AbbVie Inc. makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Nimble Therapeutics?
Nimble Therapeutics was acquired by AbbVie Inc., based in North Chicago. The deal was reported on January 23, 2025. Venture capital subsidiary of Abbvie AbbVie Inc. is publicly traded (ABBV) and operates in Manufacturing.
When did AbbVie Inc. acquire Nimble Therapeutics?
AbbVie Inc.'s acquisition of Nimble Therapeutics was reported on January 23, 2025. AbbVie has completed its acquisition of Nimble Therapeutics, adding novel oral peptide assets to its immunology pipeline. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Nimble Therapeutics do?
Nimble is a biotechnology company dedicated to delivering on the promise of peptide therapeutics. It is privately held, operating in Biotechnology, and is based in Madison.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.